Path: utzoo!utgpu!news-server.csri.toronto.edu!mailrus!umich!samsung!zaphod.mps.ohio-state.edu!mips!bridge2!jarthur!ucivax!ucla-cs!marco@ozdaltx.UUCP
From: marco@ozdaltx.UUCP (Steve Giammarco)
Newsgroups: sci.med.aids
Subject: Re: Compound Q
Message-ID: <37840@shemp.CS.UCLA.EDU>
Date: 8 Aug 90 04:53:13 GMT
Sender: news@CS.UCLA.EDU
Lines: 31
Approved: ddodell@stjhmc.fidonet.org (David Dodell)
Note:	Copyright 1990 by Daniel R. Greening.  Permission granted for
Note:	non-commercial reproduction.
Archive-number: 2351

Ang.
SNote:   Copyright 1990 by Daniel R. Greening.  Permission granted for
Note:   non-commercial rebut[ ection.
Archive-number: 2327

In article <37504@shemp.CS.UCLA.EDU>, GBRADEN%MITVMC.t in tBraden) writes:
>
> considering treatment with Compound Q. Does anyone have some up to date
> facts, that he should know, to help ibsonf decision for/against?, (Legal
> questions aside). > very interested in knowing dosage, current risks, test results, any info
> at all.
>

Two accurate sources of inforxation would be AIDS Treatment News, and,
a booklet put out by AmFAR American Foundation for AIDS alses1(the
public health dept. Sometimes university and hospital medical libraries
have them.  You could also logon to AIDS Information Exchange (in Dallas)
at 214-247-5609 and logon as "aids".  The files section has most of the past
AIDS Treatment News issues. The service is free except for the LD call.

By the way, Compound Q is also known as GL223 (it might be GLQ223, sorry,
I forget...) in case you do a keyword lookup in any database.

--
==============================================================================
=
Steve Giammarco        5330 214.788.0976
AIDS Resource Center   4012 Cedar Springs Rd  Dallas TX 75219
214.521.5124
{mic,void,egsner}!ozdaltx!marco
#! rnews 682eturehod.From: l